Statistics for Design and Synthesis of Orally Bioavailable Sphingosine Kinase 2 Selective Inhibitors
Total visits
views | |
---|---|
Design and Synthesis of Orally Bioavailable Sphingosine Kinase 2 Selective Inhibitors | 153 |
Total visits per month
views | |
---|---|
June 2024 | 0 |
July 2024 | 9 |
August 2024 | 7 |
September 2024 | 7 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
File Visits
views | |
---|---|
Sibley_CD_D_2020.pdf | 161 |
Top country views
views | |
---|---|
United States | 57 |
China | 9 |
Germany | 9 |
Japan | 7 |
India | 6 |
Ireland | 4 |
Italy | 4 |
Turkey | 3 |
Uruguay | 3 |
France | 2 |
Ghana | 2 |
Hong Kong SAR China | 2 |
Russia | 2 |
Singapore | 2 |
Australia | 1 |
Canada | 1 |
United Kingdom | 1 |
Malaysia | 1 |
Poland | 1 |
South Africa | 1 |
Top city views
views | |
---|---|
Reston | 30 |
Beijing | 5 |
Düsseldorf | 5 |
Bethesda | 3 |
Montevideo | 3 |
Castro Valley | 2 |
Central | 2 |
Dublin | 2 |
Istanbul | 2 |
Naples | 2 |
Singapore | 2 |
Taku | 2 |
Adelaide | 1 |
Bengaluru | 1 |
Boardman | 1 |
Chelyabinsk | 1 |
Chicago | 1 |
Coimbatore | 1 |
Des Moines | 1 |
Freiberg | 1 |
Johannesburg | 1 |
Magnesia ad Sipylum | 1 |
Nanjing | 1 |
New York | 1 |
Newport News | 1 |
Notre Dame | 1 |
Perugia | 1 |
Petaling Jaya | 1 |
Pittsburgh | 1 |
Richmond | 1 |
Shenzhen | 1 |
St Louis | 1 |
Vladivostok | 1 |
Warsaw | 1 |
Waterloo | 1 |
Winston-Salem | 1 |